RT Journal Article
SR Electronic
T1 Clinical evolution of COVID-19 during pregnancy at different altitudes: a population-based study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.09.14.20193177
DO 10.1101/2020.09.14.20193177
A1 Juan Alonso Leon-Abarca
A1 Maria Teresa Peña-Gallardo
A1 Jorge Soliz
A1 Roberto Accinelli
YR 2020
UL http://medrxiv.org/content/early/2020/09/18/2020.09.14.20193177.abstract
AB Background The impact of influenza and various types of coronaviruses (SARS-CoV and MERS-CoV) on pregnancy has been reported. However, the current pandemic caused by SARS-CoV-2 continues to reveal important data for understanding its behavior in pregnant women.Methods We analyzed the records of 326,586 non-pregnant women of reproductive age and 7,444 pregnant women with no other risk factor who also had a SARS-CoV-2 RT-PCR result to estimate adjusted prevalence (aP) and adjusted prevalence ratios (aPR) of COVID-19 and its requirement of hospitalization, intubation, ICU admission and case-fatality rates. Adjustment was done through Poisson regressions for age and altitude of residence and birth. Generalized binomial models were used to generate probability plots to display how each outcome varied across ages and altitudes.Results Pregnancy was independently associated with a 15% higher probability of COVID-19 (aPR: 1.15), a 116% higher probability of its following admission (aPR: 2.169) and a 127% higher probability of ICU admission (aPR: 2.275). Also, pregnancy was associated with 84.2% higher probability of developing pneumonia (aPR: 1.842) and a 163% higher probability of its following admission (aPR: 2.639). There were no significant differences in COVID-19 case-fatality rates between pregnant and non pregnant women (1.178, 95% CI: 0.68-1.67).Conclusion Pregnancy was associated with a higher probability of COVID-19, developing of pneumonia, hospitalization, and ICU admission. Our results also suggest that the risk of COVID-19 and its related outcomes, except for intubation, decrease with altitude.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe paper has not received any kind of funding aid from public agencies, the commercial sector or non-profit entities.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was waived from revision by the Universidad Peruana Cayetano Heredia IRB with registry number SIDISI 202658.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesProcessed data files used in the present study are available at request. The authors follow the STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) statement for data collection, analysis and reporting. https://www.gob.mx/salud/documentos/datos-abiertos-152127